Actively Recruiting
Treatment of Meniere's Disease With Migraine Medications
Led by University of California, Irvine · Updated on 2026-04-13
40
Participants Needed
1
Research Sites
282 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Meniere's disease (MD) is a chronic disease with a variety of fluctuating signs and symptoms, which include vertigo, hearing loss, tinnitus (ringing noise in the ear), aural pressure (feeling of ear fullness), and disequilibrium (lack of stability). Vertigo represents one of the most common and distressing problems in MD patients, and it causes various somatic and psychological disorders that interfere with the patient's quality of life. Despite the large economic and emotional impact of symptoms in MD patients, there is no FDA-approved medication to treat this debilitating condition. As such, our objective in this study is to evaluate the therapeutic potential of novel medications in treating MD that have previously shown astonishing promise in our clinical practice.
CONDITIONS
Official Title
Treatment of Meniere's Disease With Migraine Medications
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with active or frequent Meniere's Disease
- Male or female between the ages of 25 to 85 years
- Must be compliant with the medication and attend study visits
- Must be able to read and write in the English language to provide consenting
You will not qualify if you...
- Pregnancy (ruled out by urine pregnancy test for women of childbearing potential)
- History of surgery for Meniere's Disease
- History of adverse reaction to the prescribed medications
- Medical conditions or history concerning to the clinical investigator
- Presence of psychosis
- Presence of neurological neoplasm
- Any contraindications for the study medications preventing randomization
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, Irvine Medical Center ENT Clinic (Pavilion 2)
Orange, California, United States, 92868
Actively Recruiting
Research Team
H
Hamid R Djalilian
CONTACT
M
Mehdi Abouzari
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here